AFE. Ddx Acls protocol preg pt. Mx Cvs involvement and shunts seen in afr Post op considerations

Reading File

search_medical_text

amniotic fluid embolism diagnosis differential management ACLS pregnant

search_medical_text

amniotic fluid embolism cardiovascular hemodynamic shunts right heart failure coagulopathy

GradeResponse

Retrieval was limited — synthesizing a comprehensive answer from my own clinical knowledge, supplemented by the retrieved guideline fragment.

Amniotic Fluid Embolism (AFE)

Diagnosis & Pathophysiology

AFE is a rare, catastrophic obstetric emergency (incidence ~1-6/100,000 deliveries) with mortality up to 20-60%. It is not a true "embolism" but an anaphylactoid/inflammatory response to fetal antigenic material entering maternal circulation, triggering massive mediator release.

Classic Triad:

Acute hypoxia
Cardiovascular collapse
DIC/coagulopathy

Biphasic hemodynamic model:

Phase 1 (minutes): Pulmonary vasospasm → acute RV failure → hypoxia → RV dilation → interventricular septal shift → LV underfilling → systemic hypotension
Phase 2: LV dysfunction (direct myocardial depression by mediators) + distributive shock

Differential Diagnosis

Condition	Distinguishing Features
Pulmonary Embolism (PE)	Onset less acute, no DIC early, CTPA confirms, D-dimer elevated, risk factors (DVT)
Eclampsia / HELLP	HTN, proteinuria, elevated LFTs, thrombocytopenia, seizures; DIC less fulminant
Septic shock	Fever, positive cultures, focal infection source, slower progression
Anaphylaxis	Drug/latex exposure, urticaria, bronchospasm, responds to epinephrine
Peripartum cardiomyopathy	Subacute, echo shows dilated LV, no DIC
Abruption-related hemorrhage	Blood loss before cardiovascular collapse; uterus firm/tender
Air embolism	Iatrogenic (IV access, uterine manipulation), "mill-wheel" murmur, no DIC
High spinal / LA toxicity	Neuraxial procedure precedes collapse; no DIC
Uterine rupture	Abdominal pain, fetal bradycardia, surgical confirmation
Tension pneumothorax	Unilateral breath sounds, tracheal deviation, JVD

Key: AFE has no pathognomonic test. Diagnosis is clinical and exclusionary. Fetal squamous cells in maternal pulmonary vasculature are not diagnostic (present in normal pregnancies).

ACLS in the Pregnant Patient — Modified Protocol

Anatomical/Physiological Considerations

Aortocaval compression by gravid uterus reduces preload
Cricoid pressure / difficult airway (Mallampati worse in pregnancy)
Higher O₂ consumption, lower FRC → desaturates faster

Maternal Cardiac Arrest Algorithm (AHA 2020 + ACOG)

CALL FOR HELP IMMEDIATELY
→ Obstetric team + Neonatal team + Anesthesia + Cardiac surgery (ECMO)

1. POSITIONING
   - Manual Left Uterine Displacement (LUD) — DO NOT use tilted board for arrest
   - Supine with LUD (wedge ONLY if no arrest)

2. AIRWAY
   - Early RSI (aspiration risk), smallest ETT (7.0), video laryngoscopy preferred
   - Preoxygenate 100% O₂

3. COMPRESSIONS
   - Standard hand position (slightly higher on sternum if uterus large)
   - Standard 100-120/min, 2-inch depth
   - Full chest recoil

4. DEFIBRILLATION
   - NOT contraindicated; use standard energies (biphasic 200J)
   - Remove fetal monitors before shock
   - Anterior-lateral pad placement

5. DRUGS — Standard ACLS doses
   - Epinephrine 1mg IV q3-5min (safe in pregnancy)
   - Amiodarone for shockable rhythms
   - Magnesium → STOP if already running (can cause arrest)
   - Sodium bicarb for hyperkalemia/TCA only

6. PERIMORTEM CESAREAN DELIVERY (PMCD)
   ★ Begin at 4 MINUTES of arrest if no ROSC
   ★ Target delivery by 5 minutes ("4-minute rule")
   ★ Do NOT transport to OR — deliver at bedside
   ★ Gestational age ≥20 weeks (uterus at umbilicus)
   ★ Purpose: relieve aortocaval compression → improves maternal ROSC
   (fetal benefit is secondary consideration during maternal arrest)

7. POST-ROSC → ICU, ECMO consideration

Management of AFE

Immediate (simultaneous)

Priority	Action
Airway	RSI, intubate, 100% O₂, target SpO₂ >95%
Circulation	Large-bore IV ×2, arterial line, CVC
Call	MFM, anesthesia, hematology, ICU, neonatology
Vasopressors	Norepinephrine first-line for vasodilatory component; Vasopressin adjunct
RV support	Avoid fluid overload; cautious IVF; consider inhaled NO or IV milrinone for RV afterload reduction
Inotropes	Dobutamine or Epinephrine for RV/LV failure
Delivery	Expedite delivery if not yet delivered

Coagulopathy / DIC Management

Massive transfusion protocol (MTP): pRBC:FFP:Platelets = 1:1:1
Tranexamic Acid (TXA): 1g IV early (inhibits fibrinolysis)
Fibrinogen concentrate (target >2 g/L) or cryoprecipitate
PCC (4-factor) if FFP limited
rFVIIa as rescue (per retrieved guideline, Management of Severe Peri-Operative Bleeding, p. 49)
Do NOT give heparin (worsens coagulopathy)
Thromboelastography (TEG/ROTEM) guided replacement preferred

Advanced Rescue Therapies

ECMO (VA-ECMO): increasingly used early in refractory AFE arrest; can be bridge to recovery
IABP or Impella for severe LV failure
Inhaled prostacyclin (epoprostenol) or iNO for pulmonary hypertension/RV failure
Steroids (hydrocortisone 500mg): rationale is the anaphylactoid mechanism; not proven but commonly used
Atropine/Ondansetron: some evidence for vagally-mediated initial phase

Cardiovascular Involvement & Shunts in AFE

Hemodynamic Phases

Phase 1 — Acute Pulmonary Hypertension (minutes)

Fetal mediators (prostaglandins, leukotrienes, endothelin, serotonin) → pulmonary vasospasm
Sudden ↑ RV afterload → acute cor pulmonale
RV dilation → D-shaped septum (interventricular septal bowing into LV)
↓ LV preload → low CO → systemic hypotension

Phase 2 — LV Failure (minutes to hours)

Direct myocardial depression
Global LV hypokinesis on echo
Cardiogenic shock

Shunts in AFE

Shunt	Mechanism	Significance
Patent Foramen Ovale (PFO) re-opening	Acute RV pressure > LV → right-to-left shunt through PFO	Paradoxical embolism; systemic hypoxia despite O₂; stroke risk
Intrapulmonary shunting	Hypoxic pulmonary vasoconstriction overwhelmed; V/Q mismatch	Refractory hypoxemia despite FiO₂ 1.0
ASD/VSD unmasking	Pre-existing defects decompensate under acute ↑ RV pressure	New hypoxia/cyanosis; bidirectional or R→L shunting

PFO is present in ~25-30% of general population. AFE is one of the triggers that can unmask it acutely. Consider bubble contrast echo (TEE) to evaluate.

Echo Findings in AFE

RV dilation, hypokinesis
McConnell's sign (RV free wall akinesis, apex spared) — classically PE but seen in AFE
D-sign (septal shift)
TR, elevated RVSP
LV compression / underfilling
Global LV dysfunction in phase 2
Pericardial effusion (rare)

Post-operative / Post-resuscitation Considerations

ICU Management

Domain	Key Actions
Ventilation	Lung-protective strategy (tidal volume 6 mL/kg IBW, PEEP 5-10), target SpO₂ >94%
Hemodynamics	Ongoing vasopressor/inotrope titration; goal MAP >65; consider PA catheter or PiCCO for advanced monitoring
Coagulopathy	Serial TEG/ROTEM, CBC, fibrinogen q4-6h; ongoing MTP if needed; watch for heparin rebound if ECMO used
Renal	AKI common (hypoperfusion + DIC); strict fluid balance; early nephrology
Neurological	High risk of anoxic brain injury; post-arrest neuroprotection (targeted temperature management if applicable — controversial in obstetric arrest)
Uterine atony	Major hemorrhage risk post-delivery; uterotonics (oxytocin, carboprost, misoprostol); surgical options (B-Lynch, UAE, hysterectomy)
Thrombosis	Paradoxical thrombosis after DIC resolves; DVT prophylaxis once coagulopathy corrected
Infection	Broad-spectrum antibiotics if aspiration or sepsis co-exists

Neonatal Considerations

Neonatology team present at delivery
PMCD neonates may have hypoxic injury; NICU admission standard
Apgar scoring and cord gas

Psychological/Family

Debriefing for patient and family (high psychological trauma)
Multidisciplinary debrief for clinical team
Long-term: neuropsychological follow-up; PTSD screening

Prognosis

Maternal mortality: ~20-60% (older series), improving with ECMO and aggressive MTP
Neurological intact survival: ~15-40%
Recurrence in future pregnancies: rare but documented; high-risk antenatal care essential

Key Pearls:

Diagnose by exclusion — exclude PE, eclampsia, sepsis, anaphylaxis first
DIC is the rule, not the exception — activate MTP early
PMCD at 4 minutes is a maternal resuscitative intervention
PFO unmasking explains refractory hypoxemia disproportionate to the degree of pulmonary disease
VA-ECMO is the ultimate rescue — have a low threshold to activate that team
Phase 1 is RV failure; Phase 2 is LV failure — management must track the phase

This is a shared conversation. Sign in to Orris to start your own chat.